The Diagnosis and Treatment of Autoimmune Encephalitis

被引:133
|
作者
Lancaster, Eric [1 ]
机构
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
来源
JOURNAL OF CLINICAL NEUROLOGY | 2016年 / 12卷 / 01期
关键词
autoimmune; antibody; paraneoplastic; encephalitis; anti-NMDAR encephalitis; PARANEOPLASTIC CEREBELLAR DEGENERATION; D-ASPARTATE RECEPTOR; FACIOBRACHIAL DYSTONIC SEIZURES; NMDA RECEPTOR; LIMBIC ENCEPHALITIS; CLINICAL ANALYSIS; NERVOUS-SYSTEM; CASE SERIES; ANTI-TR; ANTIBODIES;
D O I
10.3988/jcn.2016.12.1.1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autoimmune encephalitis causes subacute deficits of memory and cognition, often followed by suppressed level of consciousness or coma. A careful history and examination may show early clues to particular autoimmune causes, such as neuromyotonia, hyperekplexia, psychosis, dystonia, or the presence of particular tumors. Ancillary testing with MRI and EEG may be helpful for excluding other causes, managing seizures, and, rarely, for identifying characteristic findings. Appropriate autoantibody testing can confirm specific diagnoses, although this is often done in parallel with exclusion of infectious and other causes. Autoimmune encephalitis may be divided into several groups of diseases: those with pathogenic antibodies to cell surface proteins, those with antibodies to intracellular synaptic proteins, T-cell diseases associated with antibodies to intracellular antigens, and those associated with other autoimmune disorders. Many forms of autoimmune encephalitis are paraneoplastic, and each of these conveys a distinct risk profile for various tumors. Tumor screening and, if necessary, treatment is essential to proper management. Most forms of autoimmune encephalitis respond to immune therapies, although powerful immune suppression for weeks or months may be needed in difficult cases. Autoimmune encephalitis may relapse, so follow-up care is important.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] Treatment of Anti-GAD65 Autoimmune Encephalitis With Methylprednisolone
    Azizi, Shayan
    Vadlamuri, Diamler L.
    Cannizzaro, Louis A.
    OCHSNER JOURNAL, 2021, 21 (03) : 312 - 315
  • [22] Autoimmune limbic encephalitis
    Vedeler, C. A.
    Storstein, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 : 63 - 67
  • [23] Autoimmune Encephalitis in Children
    Hardy, Duriel
    PEDIATRIC NEUROLOGY, 2022, 132 : 56 - 66
  • [24] Autoimmune encephalitis: recent clinical and biological advances
    Varley, James A.
    Strippel, Christine
    Handel, Adam
    Irani, Sarosh R.
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 4118 - 4131
  • [25] SOP: antibody-associated autoimmune encephalitis
    Roessling, Rosa
    Pruess, Harald
    NEUROLOGICAL RESEARCH AND PRACTICE, 2020, 2 (01):
  • [26] Searching for autoimmune encephalitis: Beware of normal CSF
    Hebert, Julien
    Gros, Priti
    Lapointe, Sarah
    Amtashar, Fatima S.
    Steriade, Claude
    Maurice, Catherine
    Wennberg, Richard A.
    Day, Gregory S.
    Tang-Wai, David F.
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 345
  • [27] SOP: antibody-associated autoimmune encephalitis
    Rosa Rössling
    Harald Prüss
    Neurological Research and Practice, 2
  • [28] Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
    Cellucci, Tania
    Van Mater, Heather
    Graus, Francesc
    Muscal, Eyal
    Gallentine, William
    Klein-Gitelman, Marisa S.
    Benseler, Susanne M.
    Frankovich, Jennifer
    Gorman, Mark P.
    Van Haren, Keith
    Dalmau, Josep
    Dale, Russell C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
  • [29] Autoimmune encephalitis. New diagnosis for an old condition
    Oaparo Oblitas, Ruben L.
    MEDICINA-BUENOS AIRES, 2018, 78 : 88 - 93
  • [30] Pediatric autoimmune encephalitis Recognition and diagnosis
    de Bruijn, Marienke A. A. M.
    Bruijstens, Arlette L.
    Bastiaansen, Anna E. M.
    van Sonderen, Agnes
    Schreurs, Marco W. J.
    Smitt, Peter A. E. Sillevis
    Hintzen, Rogier Q.
    Neuteboom, Rinze F.
    Titulaer, Maarten J.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (03):